Genetic Analysis AS (NGM:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 1.030
-0.020 (-1.90%)
At close: Jun 12, 2025
Genetic Analysis AS Revenue
Genetic Analysis AS had revenue of 4.01M NOK in the quarter ending March 31, 2025, a decrease of -15.88%. This brings the company's revenue in the last twelve months to 19.93M, down -7.64% year-over-year. In the year 2024, Genetic Analysis AS had annual revenue of 20.68M, down -10.71%.
Revenue (ttm)
19.93M NOK
Revenue Growth
-7.64%
P/S Ratio
2.54
Revenue / Employee
1.25M NOK
Employees
16
Market Cap
48.27M SEK
Revenue Chart
* This company reports financials in NOK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |